Gilead & Merck announce positive topline results from two phase 3 studies evaluating islatravir/lenacapavir, an oral once-weekly HIV treatment: Foster City, California Wednesday, ...
The combination of islatravir and lenacapavir targets multiple stages of HIV-1 replication, potentially offering people with HIV who are virologically suppressed a novel, long-acting oral ...
Scientists have used AI to design a universal COVID vaccine and successfully tested it in humans. Two experts weigh in on how ...
Multi-organ system and quality-of-life benefits sustained through five years of treatment– 82% response rate for the multi-component endpoint – ...
Just like snowflakes, no two TikTok For You pages look alike. And that is intentional. The social media site's highly ...
Chief Medical Officer Trang Ly said the system, which allows people to manage Type 2 diabetes without bolusing, will be ...
BMS presented trial results from mezigdomide and arlocabtagene autoleucel at EHA 2026. Credit: Tada Images/Shutterstock.com. Bristol Myers Squibb (BMS) has revealed clinical data for two pipeline ...
MITOLINE®-Enabled 3D Structural Modeling and Boltz AI Capabilities to Be Combined by MitoCareX in a Synergistic Virtual Screening Campaign for selected Transporter Targets Neve Yarak, Israel, June 22, ...
The historical paradigm of cataract surgery forced an absolute compromise: pristine distance vision with absolute spectacle ...
Vaxcyte recently completed enrollment for three Phase 3 adult clinical trials of its VAX-31 pneumococcal vaccine candidate, along with a Phase 2 VAX-31 infant study, and outlined plans to start a ...
By Leo Marchandon PARIS, June 16 (Reuters) - France's cybersecurity agency ANSSI said on Tuesday it would stop certifying ...
The path from block-based programming to vibe coding represents a shift from mastering the mechanics of implementation to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results